While nearly all patients with T1D require exogenous insulin, either through injections or a pump, to regulate blood glucose levels, if fully functional and mature β cells could be generated in a dish, they could potentially be transplanted into patients to treat, or even cure diabetes with appropriate attention to immune responses (40). The gene discussed is INS; the disease is diabetes mellitus.